Monoclonal Antibody Impact Factor

Antibodies - Impact Factor The Impact Factor 2018 of Antibodies is 0.400, which is just updated in 2019. Compared with historical Impact Factor data, the Impact Factor 2018 of Antibodies dropped by 86.67 %. The Impact Factor Quartile of Antibodies is Q1.Monoclonal Antibody. As per available reports about 3 journals, 24 Conferences, 11 workshops are presently dedicated exclusively to Biomolecules and about 255163 articles are being published on the current trends in Molecular Systems Biology. Monoclonal antibody in general is from the same parent. The impact factor of journal provides quantitative assessment tool for grading, evaluating, sorting and comparing journals of similar kind. It reflects the average number of citations to recent articles published in science and social science journals.In addition, CTLA-4, PD-1 and PD-L1 blocking antibodies are being combined with each other or with other antibodies targeting novel ICI, immunostimulatory molecules, tumor antigens, angiogenic factors, complement receptors, or with T cell engaging bispecific antibodies (BsAb), with the aim of obtaining synergistic effects with minimal toxicity. 

High Impact List of Articles
Conference Proceedings

Relevant Topics in Clinical Sciences